NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.40 -0.23 (-8.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Receivables - Other (2023 - 2025)

Updated

NRX Pharmaceuticals (NRXP) recorded Receivables - Other of $3.09 million in Q3 2025, compared with $6,000 a year earlier.

Analysis

NRX Pharmaceuticals (NRXP) Receivables - Other (2023 - 2025) Analysis & Trends

At the end of FY2023, NRX Pharmaceuticals reported Receivables - Other of $6,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 NRX Pharmaceuticals 103.58 Mn 55.17 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.09 Mn
Sep 30, 2024 6,000.00
Jun 30, 2024 6,000.00
Dec 31, 2023 6,000.00
API Access

NRX Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=NRXP&period=max&api_key=YOUR_API_KEY